The Global Nootropics Market is estimated to be valued at USD 3.66 Bn in 2024. The market is expected to reach USD 8.98 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.7% from 2024 to 2031. The global nootropics market has been witnessing steady growth over the past few years owing to the increasing awareness about cognitive enhancing supplements. Nootropics, also known as smart drugs, are substances that are designed to improve brain function and promote neuroplasticity. The rising focus on cognitive abilities and mental health has prompted many individuals to look for natural and alternative methods of brain enhancement. Moreover, busy lifestyles and increasing workload have necessitated cognitive support, especially among professionals. As a result, nootropics supplements containing compounds such as L-theanine, caffeine, Bacopa monnieri, and phosphatidylserine are gaining significant traction globally. Furthermore, growing geriatric population susceptible to neurodegenerative disorders will continue bolstering the demand for nootropics in the upcoming years.
Market Dynamics
The global nootropics market is driven by rising health consciousness, busy lifestyles, and increased focus on cognitive abilities. However, lack of clinical evidence, stringent regulations, and potential side effects of certain compounds are limiting the market growth. Growing aging population and increased research & development activities present tremendous opportunities in the market. Rising mental health issues due to stress, anxiety, and depression have enhanced the demand for supplements supporting brain health. Additionally, advancements in delivery systems and introduction of newer compounds are further expanding the scope of the market. However, ambiguity related to dosage levels and interaction with other drugs are major challenges.
Key Features of the Study
- This report provides in-depth analysis of the global nootropics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global nootropics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Onnit Labs, Inc., Qualia (Neurohacker Collective), Nootrobox, Mind Lab Pro, Alpha Brain, Genius Consciousness, HVMN, Nootropics Depot, Neurohacker Collective, Clevor, BrainMD, Herbalife Nutrition Ltd., NOW Foods, Gaia Herbs, and Prometheus
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global nootropics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nootropics market
Market Segmentation
Table of Contents
*Browse 32 market data tables and 28 figures on 'Global Nootropics Market' - Global forecast to 2031
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients